Search Results - "CHIARELLI, Laurent R"

Refine Results
  1. 1

    Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches by Scoffone, Viola C, Chiarelli, Laurent R, Trespidi, Gabriele, Mentasti, Massimo, Riccardi, Giovanna, Buroni, Silvia

    Published in Frontiers in microbiology (22-08-2017)
    “…is an opportunistic pathogen particularly dangerous for cystic fibrosis (CF) patients. It can cause a severe decline in CF lung function possibly developing…”
    Get full text
    Journal Article
  2. 2

    Antibiotics' Sustainability: Another Issue in the Fight against Antimicrobial Resistance by Buroni, Silvia, Chiarelli, Laurent R

    Published in Current topics in medicinal chemistry (01-01-2022)
    “…The spread of antimicrobial resistance (AMR) is still a major threat to global health that is likely to worsen also as a consequence of the COVID-19 pandemic…”
    Get more information
    Journal Article
  3. 3

    Quorum Sensing as Antivirulence Target in Cystic Fibrosis Pathogens by Scoffone, Viola Camilla, Trespidi, Gabriele, Chiarelli, Laurent R, Barbieri, Giulia, Buroni, Silvia

    “…Cystic fibrosis (CF) is an autosomal recessive genetic disorder which leads to the secretion of a viscous mucus layer on the respiratory epithelium that…”
    Get full text
    Journal Article
  4. 4

    Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options by Recchia, Deborah, Stelitano, Giovanni, Stamilla, Alessandro, Gutierrez, Damaris L, Degiacomi, Giulia, Chiarelli, Laurent R, Pasca, Maria Rosalia

    “…is an opportunistic pathogen that mainly colonizes and infects cystic fibrosis patients' lungs. is naturally resistant to many antibiotics such as rifamycin,…”
    Get full text
    Journal Article
  5. 5

    Structural Study of a New MbtI-Inhibitor Complex: Towards an Optimized Model for Structure-Based Drug Discovery by Mori, Matteo, Villa, Stefania, Chiarelli, Laurent R, Meneghetti, Fiorella, Bellinzoni, Marco

    Published in Pharmaceuticals (Basel, Switzerland) (01-11-2023)
    “…MbtI from Mycobacterium tuberculosis (Mtb) is a Mg2+-dependent salicylate synthase, belonging to the chorismate-utilizing enzyme (CUE) family. As a fundamental…”
    Get full text
    Journal Article
  6. 6

    Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular Agents by Mori, Matteo, Stelitano, Giovanni, Chiarelli, Laurent R, Cazzaniga, Giulia, Gelain, Arianna, Barlocco, Daniela, Pini, Elena, Meneghetti, Fiorella, Villa, Stefania

    Published in Pharmaceuticals (Basel, Switzerland) (13-02-2021)
    “…Tuberculosis (TB) causes millions of deaths every year, ranking as one of the most dangerous infectious diseases worldwide. Because several pathogenic strains…”
    Get full text
    Journal Article
  7. 7

    Improving Protection to Prevent Bacterial Infections: Preliminary Applications of Reverse Vaccinology against the Main Cystic Fibrosis Pathogens by Cocorullo, Mario, Chiarelli, Laurent R, Stelitano, Giovanni

    Published in Vaccines (Basel) (01-07-2023)
    “…Reverse vaccinology is a powerful tool that was recently used to develop vaccines starting from a pathogen genome. Some bacterial infections have the necessity…”
    Get full text
    Journal Article
  8. 8

    Engineering of Helicobacter pylori L-asparaginase: characterization of two functionally distinct groups of mutants by Maggi, Maristella, Chiarelli, Laurent R, Valentini, Giovanna, Scotti, Claudia

    Published in PloS one (09-02-2015)
    “…Bacterial L-asparaginases have been used as anti-cancer drugs for over 4 decades though presenting, along with their therapeutic efficacy, several side effects…”
    Get full text
    Journal Article
  9. 9

    Molecular insights on pathogenic effects of mutations causing phosphoglycerate kinase deficiency by Chiarelli, Laurent R, Morera, Simone M, Bianchi, Paola, Fermo, Elisa, Zanella, Alberto, Galizzi, Alessandro, Valentini, Giovanna

    Published in PloS one (14-02-2012)
    “…Phosphoglycerate kinase (PGK) catalyzes an important ATP-generating step in glycolysis. PGK1 deficiency is an uncommon X-linked inherited disorder, generally…”
    Get full text
    Journal Article
  10. 10

    Expanding targets for a metabolic therapy of cancer: L-asparaginase by Covini, Daniele, Tardito, Saverio, Bussolati, Ovidio, Chiarelli, Laurent R, Pasquetto, Maria V, Digilio, Rita, Valentini, Giovanna, Scotti, Claudia

    “…The antitumour enzyme L-asparaginase (L-asparagine amidohydrolase, EC 3.5.1.1, ASNase), which catalyses the deamidation of L-asparagine (Asn) to L-aspartic…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Structural and Energetic Basis of Protein Kinetic Destabilization in Human Phosphoglycerate Kinase 1 Deficiency by Pey, Angel L, Mesa-Torres, Noel, Chiarelli, Laurent R, Valentini, Giovanna

    Published in Biochemistry (Easton) (19-02-2013)
    “…Protein kinetic destabilization is a common feature of many human genetic diseases. Human phosphoglycerate kinase 1 (PGK1) deficiency is a rare genetic disease…”
    Get full text
    Journal Article
  16. 16

    Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug by Mori, Giorgia, Orena, Beatrice Silvia, Chiarelli, Laurent R, Degiacomi, Giulia, Riabova, Olga, Sammartino, José Camilla, Makarov, Vadim, Riccardi, Giovanna, Pasca, Maria Rosalia

    Published in Frontiers in microbiology (25-02-2020)
    “…Tuberculosis remains one of the leading causes of death from a single pathogen globally. It is estimated that 1/4 of the world's population harbors latent…”
    Get full text
    Journal Article
  17. 17

    Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia by Chiarelli, Laurent R, Scoffone, Viola Camilla, Trespidi, Gabriele, Barbieri, Giulia, Riabova, Olga, Monakhova, Natalia, Porta, Alessio, Manina, Giulia, Riccardi, Giovanna, Makarov, Vadim, Buroni, Silvia

    Published in Frontiers in microbiology (07-04-2020)
    “…There is an urgent need for new antimicrobials to treat the opportunistic Gram-negative , which represents a problematic challenge for cystic fibrosis…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity by Fan, Dongguang, Wang, Bin, Stelitano, Giovanni, Savková, Karin, Riabova, Olga, Shi, Rui, Wu, Xiaomei, Chiarelli, Laurent R, Mikušová, Katarína, Makarov, Vadim, Lu, Yu, Hong, Yuzhi, Qiao, Chunhua

    Published in Biomedicines (01-07-2023)
    “…Tuberculosis (TB) is a leading infectious disease with serious antibiotic resistance. The benzothiazinone (BTZ) scaffold PBTZ169 kills (Mtb) through the…”
    Get full text
    Journal Article